1H-Pyrrolo[3,2-d]pyrimidin-4(5H)-one

Catalog No. :
ACKDSP063
CAS No. :
5655-01-6
Molecular Formula :
C6H5N3O
Molecular Weight :
135.13

IUPAC Name:1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one

1H-Pyrrolo[3,2-d]pyrimidin-4(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$77.00Login to see priceIn stockInquiry
5g98%$156.00Login to see priceIn stockIn stock
10g98%$265.00Login to see priceIn stockIn stock
25g98%$660.00Login to see priceIn stockInquiry
100g98%$2110.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1H-Pyrrolo[3,2-d]pyrimidin-4(5H)-one
IUPAC Name1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
MDL No.MFCD09037890
Molecular FormulaC6H5N3O
Molecular Weight135.13
SMILESN1C2=C(C(N=C1)=O)[NH]C=C2
InChI KeyUWMXUDUWVFWJPX-UHFFFAOYSA-N
SynonymAB2818 | AM20100041 | F2190-0435 | L-Glutamic acid .gamma.-lactam | EN300-102659 | PB28030 | 3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | Z1198184375 | 4H-Pyrrolo[3,2-d]pyrimidin-4-one, 1,5-dihydro- | 3,5-Dihydro-pyrrolo[3,2-d]pyrimidin-4-one | 3,5-Dihydropyrro
CAS No.5655-01-6
PubChem CID135488881

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKDSP063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDLF983 route compound structure diagram
    ACHDLF983252932-49-3 In Stock
  2. Plus
  3. ACRXMN357 route compound structure diagram
    ACRXMN3576313-33-3 In Stock
  4. Then
  5. ACKDSP063 route product structure diagram
    ACKDSP0635655-01-6 In Stock
Inquiry

2. ACKDSP063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKDSP063 route product structure diagram
    ACKDSP0635655-01-6 In Stock
Inquiry

Comments (0)